Germany”s Fresenius buys 85% stakes in city based Sparsh Nephrocare
With loads of innovation and out of the box ideas that convert into startups, investors are having a tough time deciding on where to invest. There are investors who reach out to startups directly and then there are those top notch investors, who are wanted by most of the startups.